Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Triggiani

Showing results (91-100 of 146) with videos related to

Pageof 15
Sort By:
Orphanet Journal of Rare Diseases|March 12, 2015
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in ItalyAndrea Zanichelli, Francesco Arcoleo, Maria Pina Barca, et al.
Allergy|February 28, 2021
Orofacial granulomatosis: Clinical and therapeutic features in an Italian cohort and review of the literatureMaria R Galdiero, Filomena Maio, Francesco Arcoleo, et al.
Frontiers in Pharmacology|May 12, 2025
Assessment of potential drug-drug interactions in patients with hereditary angioedema from the ITACA cohort: simulations from a real-life dataset considering danazol versus berotralstatAndrea Zanichelli, Dario Cattaneo, Antonio Gidaro, et al.
The Journal of Allergy and Clinical Immunology|December 16, 2025
Prevalence of KIT D816V in anaphylaxis or systemic mast cell activationKarin Hartmann, Ivan Alvarez-Twose, Jonathan A Bernstein, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 27, 2025
Patient-Reported Outcomes and Provider Perceptions of Systemic Mastocytosis: Results From the PRISM StudyMassimo Triggiani, Jessica Hobart, Iván Alvarez-Twose, et al.
Wiener Klinische Wochenschrift|June 9, 2005
The European Competence Network on Mastocytosis (ECNM)Peter Valent, Michel Arock, Stephan C Bischoff, et al.
Theranostics|September 15, 2020
Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine conceptsPeter Valent, Cem Akin, Karin Hartmann, et al.
The Journal of Allergy and Clinical Immunology|June 21, 2020
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinionsPeter Valent, Cem Akin, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 14, 2017
Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical PracticeIlaria Baiardini, Fulvio Braido, Giorgia Molinengo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 10, 2019
Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation SyndromePeter Valent, Cem Akin, Patrizia Bonadonna, et al.
Pageof 15

Showing results (91-100 of 146) with videos related to

Sort By:
Pageof 15
Orphanet Journal of Rare Diseases|March 12, 2015
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in ItalyAndrea Zanichelli, Francesco Arcoleo, Maria Pina Barca, et al.
Allergy|February 28, 2021
Orofacial granulomatosis: Clinical and therapeutic features in an Italian cohort and review of the literatureMaria R Galdiero, Filomena Maio, Francesco Arcoleo, et al.
Frontiers in Pharmacology|May 12, 2025
Assessment of potential drug-drug interactions in patients with hereditary angioedema from the ITACA cohort: simulations from a real-life dataset considering danazol versus berotralstatAndrea Zanichelli, Dario Cattaneo, Antonio Gidaro, et al.
The Journal of Allergy and Clinical Immunology|December 16, 2025
Prevalence of KIT D816V in anaphylaxis or systemic mast cell activationKarin Hartmann, Ivan Alvarez-Twose, Jonathan A Bernstein, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 27, 2025
Patient-Reported Outcomes and Provider Perceptions of Systemic Mastocytosis: Results From the PRISM StudyMassimo Triggiani, Jessica Hobart, Iván Alvarez-Twose, et al.
Wiener Klinische Wochenschrift|June 9, 2005
The European Competence Network on Mastocytosis (ECNM)Peter Valent, Michel Arock, Stephan C Bischoff, et al.
Theranostics|September 15, 2020
Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine conceptsPeter Valent, Cem Akin, Karin Hartmann, et al.
The Journal of Allergy and Clinical Immunology|June 21, 2020
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinionsPeter Valent, Cem Akin, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 14, 2017
Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical PracticeIlaria Baiardini, Fulvio Braido, Giorgia Molinengo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 10, 2019
Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation SyndromePeter Valent, Cem Akin, Patrizia Bonadonna, et al.
Pageof 15